Published in Liver Transpl on June 01, 2001
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg (2006) 1.66
Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL). J Hepatol (2014) 1.56
Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36
Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation (2007) 1.26
Live donors in liver transplantation. Gastroenterology (2008) 1.17
Quality of life for donors after living donor liver transplantation: a review of the literature. Liver Transpl (2010) 0.98
Prevention of poor psychosocial outcomes in living organ donors: from description to theory-driven intervention development and initial feasibility testing. Prog Transplant (2012) 0.96
A review of life quality in living donors after liver transplantation. Int J Clin Exp Med (2015) 0.85
Who is willing to take the risk? Assessing the readiness for living liver donation in the general German population. J Med Ethics (2006) 0.83
Proceed with caution: live living donation of lobes of liver for transplantation. Liver Transpl (2001) 0.81
Uterus transplantation: current progress and future prospects. Int J Womens Health (2016) 0.81
Adult-to-adult Right Hepatic Lobe Living Donor Liver Transplantation. Curr Treat Options Gastroenterol (2002) 0.80
Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study. Transplantation (2016) 0.79
Predictors of donor follow-up after living donor liver transplantation. Liver Transpl (2014) 0.79
Quality of life and psychological outcome of donors after living donor liver transplantation. World J Gastroenterol (2012) 0.78
Reliability and validity of a new living liver donor quality of life scale. Surg Today (2013) 0.78
Analysis of complications in hepatic right lobe living donors. Ann Saudi Med (2010) 0.78
Mental health status after living donor hepatectomy. Medicine (Baltimore) (2017) 0.75
Living donor liver transplantation: eliminating the wait for death in end-stage liver disease? Nat Rev Gastroenterol Hepatol (2017) 0.75
Predictors of Diarrhea after Hepatectomy and Its Impact on Gastrointestinal Quality of Life in Living Donors. PLoS One (2016) 0.75
Long-term medical and psychosocial outcomes in living liver donors. Am J Transplant (2016) 0.75
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA (1995) 4.45
Recovery and management options for spring/summer chinook salmon in the Columbia River basin. Science (2000) 4.08
Focal cortical presentations of Alzheimer's disease. Brain (2007) 4.07
Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem (1983) 3.91
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry (2000) 2.90
Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr Biol (2000) 2.79
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA (1997) 2.78
A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology (1980) 2.39
Cytokines in alcoholic liver disease. Semin Liver Dis (1999) 2.37
Animal research in liver transplantation with special reference to the dog. Semin Liver Dis (1985) 2.28
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
Low flow venovenous bypasses in small dogs and pediatric patients undergoing replacement of the liver. Surg Gynecol Obstet (1986) 2.00
Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant (2007) 1.70
The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology (1999) 1.68
Adult living donor liver transplantation using a right hepatic lobe. Transplantation (1998) 1.59
Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology (1982) 1.57
Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet (1991) 1.55
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet (1997) 1.53
Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology (1997) 1.45
Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection. Am J Gastroenterol (1995) 1.45
Extrarenal manifestations of autosomal dominant polycystic kidney disease. Semin Nephrol (1991) 1.45
Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet (1996) 1.42
Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Liver Transpl Surg (1999) 1.42
Adult-to-adult living donor liver transplantation using right-lobe grafts: results and lessons learned from a single-center experience. Liver Transpl (2001) 1.38
Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology (1990) 1.36
Outcome of fetal ventriculomegaly. Lancet (1984) 1.35
Aerobic exercise capacity at sea level and at altitude in Kenyan boys, junior and senior runners compared with Scandinavian runners. Scand J Med Sci Sports (1995) 1.32
Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant (2012) 1.32
Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology (1987) 1.30
Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology (1987) 1.24
Role of bile and bile salts on cyclosporine absorption in dogs. Transplant Proc (1987) 1.24
Benign focal lesions of the liver. Clin Liver Dis (2001) 1.15
The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther (2014) 1.14
Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology (1994) 1.14
HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J Virol (2008) 1.13
Identification of lesion components that influence visual function in age related macular degeneration. Br J Ophthalmol (2003) 1.12
Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle. J Clin Invest (1981) 1.10
Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. Am J Transplant (2012) 1.10
Portal vein thrombolysis and closure of competitive shunts following liver transplantation. J Vasc Interv Radiol (1994) 1.09
Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation (1996) 1.08
Maintenance interferon for chronic hepatitis C: more issues than answers? Hepatology (2000) 1.06
HepG2. A human hepatoblastoma cell line exhibiting defects in bile acid synthesis and conjugation. J Biol Chem (1986) 1.06
Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. PCR Methods Appl (1992) 1.05
Laparoscopic palliation of polycystic liver disease. Surg Endosc (2004) 1.04
Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation. Liver Transpl Surg (1997) 1.04
Complete detection of mutations in cystic fibrosis patients of Native American origin. Hum Genet (1994) 1.04
Gastrointestinal transit time in human pregnancy: prolongation in the second and third trimesters followed by postpartum normalization. Gastroenterology (1985) 1.04
Short-term regulation of bile acid uptake by microfilament-dependent translocation of rat ntcp to the plasma membrane. Hepatology (1999) 1.03
Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation (1995) 1.03
An essential role for Rac/Cdc42 GTPases in cerebellar granule neuron survival. J Biol Chem (2001) 1.02
Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats. Biochem J (1991) 1.01
Phosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complex. AIDS (1987) 1.01
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation (1998) 1.00
Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol (1988) 0.99
Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Transplantation (1997) 0.99
CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene (1995) 0.98
Steady-state kinetics of serum bile acids in healthy human subjects: single and dual isotope techniques using stable isotopes and mass spectrometry. J Lipid Res (1987) 0.94
Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. Psychiatry Res (2001) 0.93
Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus. Liver Transpl (2001) 0.93
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. Transplant Proc (2005) 0.93
Endoscopic stenting of the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease awaiting orthotopic liver transplantation. Liver Transpl Surg (1999) 0.92
Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation (2000) 0.92
Immunosuppression in liver transplantation. Minerva Chir (2003) 0.92
Contraceptive steroids increase cholesterol in bile: mechanisms of action. J Lipid Res (1987) 0.91
Outcomes of donor evaluations for adult-to-adult right hepatic lobe living donor liver transplantation. Am J Transplant (2006) 0.90
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation (2000) 0.90
The etiology of "white bile" in the biliary tree. J Surg Res (1984) 0.89
Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss. Hepatology (1997) 0.89
Coordination of gastric and gallbladder emptying after ingestion of a regular meal. Gastroenterology (1983) 0.89
A placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel: a novel potential intravaginal virucide. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.88
Immunosuppressive drug-induced leukoencephalopathy in patients with liver transplant. Eur J Gastroenterol Hepatol (1998) 0.88
Liver transplantation for alcoholic liver disease: bias, beliefs, 6-month rule, and relapse--but where are the data? Liver Transpl (2000) 0.88
Evaluation of 100 patients for living donor liver transplantation. Liver Transpl (2000) 0.87
Hepatofugal portal flow in cirrhosis: observations on hepatic hemodynamics and the nature of the arterioportal communications. Hepatology (1988) 0.87
Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy. HIV Med (2006) 0.86